News

QuickChek – September 15, 2021

Markets
0 min read



PDS Biotech Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

PDS Biotechnology Corporation announced that the compensation committee of the board of directors of the Company approved, on September 13, 2021, an equity award to Gregory Reid, the Company’s new VP of Program Development, as a material inducement to Mr. Reid entering into employment with PDS Biotech.

Research, News & Market Data on PDS Biotech

Watch recent presentation from PDS Biotech



Esports Entertainment Group’s ggCircuit Partners with Square on Retail Integration Software

Esports Entertainment Group announced they have joined forces with world-leading point of sale and payment processing provider, Square (NYSE: SQ), to create ggLeap, a premium esports center management software

Research, News & Market Data on EEG

Watch recent presentation from EEG



Indonesia Energy Discovers Oil in Its Second Back-to-Back New Well at Kruh Block

Indonesia Energy announced that it has discovered oil in its “Kruh 26” well after having announced in July the discovery of oil in its Kruh 25 well

Research, News & Market Data on Indonesia Energy

Watch recent presentation from Indonesia Energy



electroCore Announces New Patent Expanding Claims Related to Delivery of Non-Invasive Vagus Nerve Stimulation Therapy Using Mobile Devices

electroCore announced that the United States Patent and Trademark Office has issued US Patent No. 11,097,102 to electroCore

Research, News & Market Data on electroCore



Lifeist Wellness Announces Debut of New Ticker “LFST” on TSX Venture Exchange

Lifeist Wellness announced that as part of its corporate name change and rebrand from “Namaste Technologies Inc.” to “Lifeist Wellness Inc.”, the Company’s common shares will continue to be publicly traded on the TSX Venture Exchange (the “TSXV”) under the new ticker symbol (“LFST”)

News & Market Data on Lifeist Wellness



Data From Ongoing Clinical Trial Continues to Demonstrate a Single Administration of OpRegen® Can Provide Anatomical and Functional Improvements in Patients With Dry AMD With Geographic Atrophy

Lineage Cell Therapeutics announced updated interim results from its ongoing, 24-patient Phase 1/2a clinical study of its lead product candidate, OpRegen

Research, News & Market Data on Lineage Cell Therapeutics

Watch recent presentation from Lineage Cell Therapeutics



CanAlaska Options Key Extension Uranium Project

CanAlaska Uranium announced it has entered into a Letter of Intent with Durama Enterprises Limited

Research, News & Market Data on CanAlaska

Watch recent presentation from CanAlaska

 

Stay up to date. Follow us:

 
Share

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.